STOCK TITAN

MetLife Form 144 Discloses Proposed 221-Share Sale via Bernstein

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

MetLife, Inc. (MET) filed a Form 144 reporting a proposed sale of 221 shares of common stock through Bernstein Institutional Services LLC with an aggregate market value of $17,474.47. The notice lists the company’s outstanding shares as 665,026,054 and an approximate sale date of 09/19/2025. The shares were originally acquired on 05/29/2015 in a purchase from Goldman Sachs with cash payment on 06/03/2015. The filing also discloses several recent sales by MetLife-related accounts between 06/20/2025 and 07/31/2025 totaling multiple transactions and varying gross proceeds.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Small scheduled insider sale; disclosed per Rule 144 with recent related-account sales noted; appears immaterial to market capitalization.

The form documents a proposed sale of 221 shares valued at $17,474.47 against total outstanding shares of 665,026,054, indicating the transaction is extremely small relative to the company’s float. The filer reports acquisition details (05/29/2015 purchase from Goldman Sachs) and cash payment on 06/03/2015, meeting Rule 144 disclosure requirements. The filing also lists several recent sales by MetLife-managed accounts with specified quantities and gross proceeds, which provide context but do not, by themselves, indicate material shifts in ownership or control.

TL;DR: Documentation complies with Rule 144 disclosure norms; no material adverse facts presented in the notice.

The submission includes broker details, acquisition history, payment method, and recent aggregated sales by MetLife-related accounts. The filer’s attestation that they are unaware of undisclosed material adverse information is present. From a compliance perspective, the form contains the expected elements to satisfy Rule 144 reporting for an intended sale and records previous transactions relevant to aggregation rules.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does MET's Form 144 report?

The Form 144 reports a proposed sale of 221 shares of MetLife common stock with an aggregate market value of $17,474.47.

When is the approximate sale date listed on MET's Form 144?

The approximate date of sale is listed as 09/19/2025.

Who is the broker named for the proposed sale in MET's filing?

The broker named is Bernstein Institutional Services LLC, 245 Park Ave, New York, NY 10167.

When and how were the 221 shares acquired according to the filing?

The shares were acquired on 05/29/2015 via a purchase from Goldman Sachs with payment in cash on 06/03/2015.

Does the filing show recent related sales by MetLife accounts?

Yes; the filing lists several recent sales by MetLife-related accounts between 06/20/2025 and 07/31/2025 with specified quantities and gross proceeds.
MetLife

NYSE:MET

MET Rankings

MET Latest News

MET Latest SEC Filings

MET Stock Data

51.33B
550.65M
0.25%
91.63%
1.37%
Insurance - Life
Life Insurance
Link
United States
NEW YORK